Abstract

The Federal Framework on Lyme Disease Act required the federal government to develop a Federal Framework on Lyme Disease. To do this, the Public Health Agency of Canada held a conference with a wide variety of stakeholders who shared their experiences with Lyme disease, and discussed current knowledge and research. A draft version of the Framework was publicly posted on Canada.ca for a 30-day public consultation period. The final report, Lyme Disease in Canada: A Federal Framework was released in May 2017. The Framework includes the three pillars of surveillance; education and awareness; and guidelines and best practices. Implementation will require the involvement and collaboration of all stakeholders and all levels of government, with the Government of Canada committed to collaborating with domestic and international partners to exchange best practices in the prevention, diagnosis and treatment of Lyme disease.

Highlights

  • The Federal Framework on Lyme Disease Act, which received Royal Assent on December 16, 2014, required the federal government to develop a Federal Framework on Lyme Disease that would bring a sense of cohesiveness to surveillance, education and awareness, and guidelines and best practices efforts

  • To inform the development of this Framework, the Public Health Agency of Canada, on behalf of the Minister of Health, held a conference with over 500 participants. Their families and others shared their experiences with Lyme disease, while Lyme disease experts provided information on current knowledge and research related to Lyme disease treatment, prevention, diagnosis and management

  • It should be noted that ticks carrying Lyme disease are active through much of the year; bites leading to human infection are much more common during the spring and summer months

Read more

Summary

Introduction

The Federal Framework on Lyme Disease Act, which received Royal Assent on December 16, 2014, required the federal government to develop a Federal Framework on Lyme Disease that would bring a sense of cohesiveness to surveillance, education and awareness, and guidelines and best practices efforts. To inform the development of this Framework, the Public Health Agency of Canada, on behalf of the Minister of Health, held a conference with over 500 participants. Lyme disease patients, their families and others shared their experiences with Lyme disease, while Lyme disease experts provided information on current knowledge and research related to Lyme disease treatment, prevention, diagnosis and management. It is intended to be a first step in guiding concrete action in areas where the federal government has a role. This is a synopsis of the full report

Background
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call